A detailed history of Cwm, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 273 shares of NRIX stock, worth $5,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares
273
Previous 142 92.25%
Holding current value
$5,612
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$18.93 - $25.69 $2,479 - $3,365
131 Added 92.25%
273 $6,000
Q2 2024

Jul 09, 2024

BUY
$12.02 - $21.3 $1,706 - $3,024
142 New
142 $3,000
Q4 2022

Feb 01, 2023

BUY
$9.86 - $14.59 $345 - $510
35 New
35 $0

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $969M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.